News Focus
News Focus
Followers 43
Posts 5340
Boards Moderated 0
Alias Born 12/05/2021

Re: ATLnsider post# 774103

Friday, 07/04/2025 5:16:05 AM

Friday, July 04, 2025 5:16:05 AM

Post# of 821986

Hopeforthefuture3, this is very common misconception, and often repeated Bear narrative.

aah so Dr Liau (which Hopeforthefuture3 literally quoted on this but you skipped that of course) and the the American Brain Tumor Association are bears now, according to you? Ok got it


https://www.raps.org/News-and-Articles/News-Articles/2023/5/Stakeholders-want-more-clarity-from-FDA-on-using-d

An FDA proposal to require the inclusion of patient-level data in marketing applications may prevent the use of external controls for some rare diseases, the American Brain Tumor Association said in their comment. “[I]ndividual patient-level data (IPD) is not always available for many cancers and other rare diseases,” they wrote. “This is due to many barriers that interfere with data sharing in healthcare




Dr Liau:


oh yeah let's see as far as the control group goes was
33:36
there any thought or discussion with the FDA about using external controls instead of randomization to receive both
33:43
yes we we looked at that briefly FDA would not accept any external control plan that we presented to them
33:50
um what they had offered was that we had to look at patient level external controls what that means is that every
33:56
patient on study would have to be matched with a patient from a database and as we pursued the databases that
34:03
were out there which is kind of surprising to us there's not enough data to match these individual patients

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News